UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000062422 |
|---|---|
| Receipt number | R000071444 |
| Scientific Title | Follow-up interview study on perceptions of the impact of daily alcohol consumption and acceptability of digital support |
| Date of disclosure of the study information | 2026/08/31 |
| Last modified on | 2026/07/31 14:43:52 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Follow-up interview study on perceptions of the impact of daily alcohol consumption and acceptability of digital support
Acronym
Follow-up interview study on perceptions of the impact of daily alcohol consumption and acceptability of digital support
Scientific Title
Follow-up interview study on perceptions of the impact of daily alcohol consumption and acceptability of digital support
Scientific Title:Acronym
Follow-up interview study on perceptions of the impact of daily alcohol consumption and acceptability of digital support
Region
| Japan |
Condition
Condition
Healthy subjects
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This study will be conducted to examine perceptions of the effects of alcohol consumption on sleep, physical condition, work performance, and other aspects of daily life, as well as the acceptability of, trust in, and concerns about digital support technologies.
Basic objectives2
Others
Basic objectives -Others
Qualitative interview study on perceptions, acceptability, and concerns regarding digital support
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Qualitative themes regarding perceptions of the effects of alcohol consumption on sleep, physical condition, work, etc., and acceptability, trust, concerns, etc. regarding digital support technology
Key secondary outcomes
Qualitative themes regarding conditions under which behavioral changes may occur and factors hindering them
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 40 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1. Persons who participated in the relevant prior study
2. Persons who have received a sufficient explanation regarding the purpose and contents of this study, have the capacity to give informed consent, can understand the details well, and give their own consent via electronic informed consent
Key exclusion criteria
1. Persons who did not participate in the relevant prior study
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Takahiro |
| Middle name | |
| Last name | Masuda |
Organization
Asahi Quality & Innovations, Ltd.
Division name
Next Beverage Laboratories
Zip code
302-0106
Address
1-21, Midori 1-chome, Moriya-shi, Ibaraki, Japan
TEL
0297-46-1111
takahiro.masuda@asahi-qi.co.jp
Public contact
Name of contact person
| 1st name | Ayumi |
| Middle name | |
| Last name | Sugioka |
Organization
Macromill Carenet, Inc.
Division name
Clinical Research Solution Division
Zip code
108-0075
Address
Shinagawa East One Tower 11F, 2-16-1 Konan, Minato-ku, Tokyo, Japan
TEL
03-6716-7108
Homepage URL
umin_info@macromillcarenet.jp
Sponsor or person
Institute
Macromill Carenet, Inc.
Institute
Department
Personal name
Funding Source
Organization
Asahi Quality & Innovations, Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethical Committee of Kobuna Orthopedics Clinic
Address
311-2 Joto-machi, Maebashi-shi, Gumma
Tel
027-212-5608
sagawa@mc-connect.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 08 | Month | 31 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 07 | Month | 30 | Day |
Date of IRB
| 2026 | Year | 07 | Month | 30 | Day |
Anticipated trial start date
| 2026 | Year | 07 | Month | 31 | Day |
Last follow-up date
| 2026 | Year | 08 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
-
Management information
Registered date
| 2026 | Year | 07 | Month | 31 | Day |
Last modified on
| 2026 | Year | 07 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071444
